Rectal Adenoma Clinical Trials

23 recruitingLast updated: May 29, 2026

There are 23 actively recruiting rectal adenoma clinical trials across 9 countries. Studies span Not Applicable, Phase 1, Phase 2, Phase 4. Top locations include Boston, Massachusetts, United States, Barcelona, Spain, Ann Arbor, Michigan, United States. Updated daily from ClinicalTrials.gov.


Rectal Adenoma Trials at a Glance

23 actively recruiting trials for rectal adenoma are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in Boston, Barcelona, and Ann Arbor. Lead sponsors running rectal adenoma studies include Chinese University of Hong Kong, Shanghai Jiao Tong University School of Medicine, and Massachusetts General Hospital.

Browse rectal adenoma trials by phase

Treatments under study

About Rectal Adenoma Clinical Trials

Looking for clinical trials for Rectal Adenoma? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Rectal Adenoma trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Rectal Adenoma clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 23 trials

Recruiting
Not Applicable

BILe Acid-gut Microbiome Axis MODification Through Diet Education for Colorectal Cancer Prevention

Colorectal AdenomaColorectal Cancer Prevention
Massachusetts General Hospital40 enrolled1 locationNCT07162337
Recruiting
Phase 1

Testing for Safety and Colorectal Cancer Preventive Effects of ONC201

Colorectal CarcinomaFamilial Adenomatous PolyposisColorectal Adenomatous Polyp+1 more
National Cancer Institute (NCI)36 enrolled5 locationsNCT05630794
Recruiting
Not Applicable

Colonoscopy vs Stool Testing for Older Adults With Colon Polyps

Colorectal, CancerColorectal NeoplasmsColorectal Polyp+2 more
Dartmouth-Hitchcock Medical Center8,946 enrolled22 locationsNCT05612347
Recruiting
Not Applicable

PARADIGM - En Bloc Trial With the EndoQuest Endoluminal Surgical (ELS) System

Colorectal PolypColorectal AdenomaColorectal Lesion+5 more
EndoQuest Robotics, Inc.56 enrolled6 locationsNCT06133387
Recruiting

Application Evaluation Research on the Artificial Intelligence-assisted Support System for the Diagnosis of Colorectal Tubular Adenoma Lesions

Artificial Intelligence (AI)Colorectal Adenoma
Renmin Hospital of Wuhan University4,000 enrolled1 locationNCT07073430
Recruiting
Phase 1

Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors

Colorectal AdenomaColorectal Cancer Prevention
Massachusetts General Hospital20 enrolled1 locationNCT07095517
Recruiting
Phase 4

Multi-center Randomized Controlled Clinical Study of Shenling Baishu Granule to Prevent the Recurrence of Low-risk Colorectal Adenoma

Low-risk Colorectal Adenoma
Shanghai Jiao Tong University School of Medicine624 enrolled1 locationNCT06930157
Recruiting
Not Applicable

Enhanced White Light Endoscopy Versus Conventional White Light Endoscopy for Colorectal Adenoma Detection: A Randomized Controlled Trial

Colorectal Adenoma
Shanghai Jiao Tong University School of Medicine800 enrolled7 locationsNCT06979232
Recruiting
Not Applicable

Performance and Safety of MiWEndo-assisted Colonoscopy (MiWEndo II)

Colorectal, CancerColorectal NeoplasmsColorectal Adenocarcinoma+3 more
MiWEndo Solutions S.L.50 enrolled1 locationNCT05988645
Recruiting

New bioMarkers tO straTIfy cOlorectal caNcer Referrals

Colorectal CarcinomaColorectal AdenomaPolyp
Queen Mary University of London582 enrolled1 locationNCT07035691
Recruiting
Not Applicable

A Novel Oral Synbiotic Formula in Reducing Advanced Adenoma Recurrence and Colorectal Neoplasia-related Bacterial Gene Markers

Colorectal, CancerColorectal NeoplasmsColorectal Adenoma+1 more
Chinese University of Hong Kong649 enrolled2 locationsNCT05592886
Recruiting

Development and Validation of Microbiota and Metabolite-based Prediction Model for Recurrence of High-risk Colorectal Polyps After Polypectomy

Colorectal Cancer RecurrentColorectal PolypColorectal Adenoma
Peking Union Medical College Hospital150 enrolled1 locationNCT06957626
Recruiting

Early Detection of Advanced Adenomas and Colorectal Cancer

Colorectal, CancerColorectal NeoplasmsColorectal Adenocarcinoma+15 more
City of Hope Medical Center2,000 enrolled6 locationsNCT06342440
Recruiting

Circulating Tumor DNA in Patients Summoned for Colonoscopy; - a Liquid Biopsy for Detection, Characterization, Individualized Treatment and Follow-up of Colorectal Cancer

Colorectal, CancerColorectal Adenoma
Helse Nord-Trøndelag HF3,000 enrolled1 locationNCT06307938
Recruiting
Not Applicable

Evaluation of a CAM System for Colorectal Polyp Size Measurement

Colorectal PolypColorectal Adenoma
Changhai Hospital168 enrolled1 locationNCT06715384
Recruiting
Phase 2

Evaluation of Gixam's Performance in a FIT Negative Population

Colorectal Cancer (CRC)Colorectal AdenomaColorectal Cancer (CRC) Screening
Jubaan Ltd.400 enrolled1 locationNCT06612281
Recruiting

6-year Follow-up Data After the Berberine Intervention Trial

Colorectal Cancer Control and PreventionColorectal AdenomaColorectal Polyps
Shanghai Jiao Tong University School of Medicine891 enrolled1 locationNCT06629051
Recruiting

Early Diagnosis of Colorectal Cancer Based on a Non-invasive Metabolomics Profile

Colorectal, CancerHealthyColorectal Polyp+1 more
Institut Investigacio Sanitaria Pere Virgili2,000 enrolled2 locationsNCT06452745
Recruiting

Diagnostic Accuracy of a Panel of Bacterial Gene Markers (M3) for Colorectal Advanced Neoplasia

Colorectal, CancerColorectal NeoplasmsColorectal Adenoma
Chinese University of Hong Kong2,500 enrolled1 locationNCT05405673
Recruiting

Diagnostic Accuracy of M3 in Predicting Colorectal Advanced Adenoma Recurrence (M3-AA)

Colorectal PolypColorectal AdenomaAdvanced Adenoma
Chinese University of Hong Kong600 enrolled1 locationNCT05144152